An Algerian perspective on non-typhoidal Salmonella infection by Djeghout, Bilal et al.
 Regional Review 
 
An Algerian perspective on non-typhoidal Salmonella infection 
 
Bilal Djeghout1, Ammar Ayachi2, Bianca Paglietti1, Gemma C Langridge3, Salvatore Rubino1 
 
1 Laboratory of Microbiology and Virology, Department of Biomedical Sciences, University of Sassari, Sassari, Italy 
2 Laboratory of Microbiology and Immunology, Institute of Veterinary Science and Agronomic Sciences, University 
of Batna, Algeria 
3 Medical Microbiology Research Laboratory, Norwich Medical School, University of East Anglia, Norwich, United 
Kingdom 
 
Abstract 
Non-typhoidal Salmonella (NTS) represents a leading cause of food-borne disease worldwide. It is a global public health concern: more than 
94 million cases and 115,000 deaths are reported every year, with a disproportionate impact in developing countries. The prevalence of multi-
drug-resistant (MDR) Salmonella strains is another major health concern which affects antimicrobial treatment, as many studies report that 
infections caused by MDR strains are more severe than those caused by susceptible strains. In Algeria, NTS represent one of the primary causes 
of salmonellosis in both humans and food animal production, especially poultry. Epidemiological surveillance systems and monitoring 
programs for Salmonella infections are essential requirements to provide data useful for the effective detection and control of Salmonella 
outbreaks. The present review will supply a perspective on NTS infection, pathogenesis and antimicrobial resistance with a focus on the 
epidemiology of salmonellosis in Algeria. 
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Background 
Salmonella infections are a primary concern for 
public health worldwide [1]. Salmonella is a Gram 
negative facultative anaerobe belonging to the 
Enterobacteriaceae [2]. Salmonella enterica is 
classified into more than 2500 serotypes based on two 
antigenic determinants: the somatic (O) antigen, and 
flagellar (H: phases 1 and 2) antigen [3,4] and clinically 
divided into  two groups based upon the disease caused: 
typhoidal and non-typhoidal  salmonellosis. Despite 
close genetic relatedness, typhoidal and non-typhoidal 
Salmonella (NTS) provoke different illnesses and a 
divergent response from the human immune system [5]. 
The Centers of Disease Control and Prevention (CDC) 
estimate that globally there are 94 million of cases of 
non-typhoidal salmonellosis, with 115,000 deaths every 
year [6]. Infection due to NTS is mainly associated with 
the consumption of contaminated raw meat, eggs and 
chicken, milk and other dairy products, fish and other 
sea foods, fruits and vegetables [7]. Food-borne NTS 
infection has a significant economic impact in both 
high- and low-income countries in terms of prevention 
and surveillance systems [8].  
The concern with NTS infection has heightened 
after the emergence of multidrug-resistant Salmonella 
strains, as these pathogens are more virulent and 
responsible for adverse outcomes in infected patients 
[9]. In Algeria, several outbreaks of salmonellosis have 
been observed during recent years in both humans and 
food animal production, particularly poultry [10]. 
Lapses in hygiene practices are a major cause of food-
borne NTS disease in humans, as well as the 
consumption of contaminated eggs and egg products 
with Salmonella enterica subspecies enterica serovar 
Typhimurium (hereafter S. Typhimurium) and S. 
Enteritidis [11]. 
 
Pathogenesis 
NTS are transmitted by the oral–fecal route via 
contaminated food and water and are mostly associated 
with inadequate sanitation and hygiene [12].  
NTS cause a gastrointestinal infection which 
presents as inflammation manifested with diarrhea, 
nausea, vomiting, and headache [13]. The severity of 
infection varies depending on two factors; the serotype 
implicated and the health of the patient [14]. Infants, the 
elderly, and immunocompromised patients are more 
Djeghout et al. – NTS in Algeria        J Infect Dev Ctries 2017; 11(8):583-590. 
584 
susceptible to NTS infections than healthy adults [14]. 
Although less common, some NTS actively invade 
intestinal epithelial cells using a type III secretion 
system (TTSS) to inject effector proteins into host cells, 
causing bacteremia [15]. 
 
Mechanisms of pathogenesis 
A range of virulence genes contribute to Salmonella 
pathogenicity [16].Virulence determinants can be 
harbored on the chromosome, usually encoded on 
pathogenicity islands, or on plasmids and 
bacteriophages [9]. Moreover, cells of salmonella are 
surrounded by an outer membrane containing 
lipopolysaccharide (LPS) which is able to release lipid 
A endotoxin, potentially causing shock in the host [17]. 
Another component of virulence is the ability to 
synthesize enterobactin [18]. Enterobactin is a 
siderophore secreted by Salmonella allowing it to 
sequester iron from the host and use it for growth [19]. 
Salmonella actively invade intestinal epithelial cells 
using a type III secretion system (TTSS) to inject 
effector proteins into host cells [15]. Salmonella 
pathogenicity island 1 (SPI-1) encodes genes required 
in the invasion process, while SPI-2 encodes genes 
involved in intracellular survival and replication in 
phagocytic and non-phagocytic cells, and has a crucial 
role in systemic infection [20]. 
 
Therapy for NTS infection 
Treatment for NTS infection does not usually 
require antimicrobials, because these do not reduce the 
duration or acuteness of gastroenteritis, and instead may 
result in extended carriage and appearance of resistant 
strains [21,22]. Nevertheless, antimicrobial therapy is 
considered for patients with severe diarrhea [6], and is 
commonly used for invasive salmonellosis or when 
individuals with immunodeficiency are affected [22]. 
 
Salmonellosis in Algeria 
Contaminated poultry meat is one of the main 
sources of food-borne Salmonella in humans [23]. 
According to the Global Food-borne Infections 
Network (GFN) there is a lack of surveillance projects 
and initiatives in many developing countries which has 
led to an underreporting of Salmonella serovars in 
humans and from food sources [24]. Poor diagnostic 
capacity contributes to a lack of available data in 
developing countries; in contrast most data on 
Salmonella serovar distribution are available from 
industrialized countries [25]. 
In Algeria, there are few studies on the spread and 
distribution of serovars, or antimicrobial resistance in 
NTS. One reported superficial Salmonella 
contamination in ovine and bovine carcasses sampled 
from the slaughterhouse [26] but the remainder which 
include Salmonella tend to focus only on isolates from 
Figure 1. Geographical location and distribution of reported NTS infection with a focus on North Algeria. Colors represent cities where 
NTS infection has been reported in the last 12 years. 
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clinical or animal sources (essentially from broiler 
and/or laying-hen flocks) [10,27-29]. To date, these 
studies have been reported information from various 
cities in Algeria, including Algiers, Boumerdes, Tizi-
Ouzou, Bouira, Bejaia, Constantine, Batna, Annaba and 
El Taref (Figure 1) and are summarized below [10,28-
33].  
One study from Algiers showed the detection of 
multiple Salmonella serovars contaminating a wide 
variety of raw meat and processed meat products, 
particularly from laying-hens [28,32] (Table 1). It is 
thought that this contamination probably takes place 
during meat processing at the retail level where more 
surfaces are exposed, as meat is deboned, cut into 
pieces, and minced [34]. Data from Batna, in eastern 
Algeria, identified the most common Salmonella 
serovars in broilers and laying breeding reproducers as 
S. Typhimurium and S. Livingstone, detected at a rate 
of 12% and 1.6 % respectively in poultry feces, cloacal 
swabs and dusty surfaces. In addition, all the S. 
Typhimurium isolates were resistant to ampicillin, 
ticarcillin, chloramphenicol and 
trimethoprim/sulfamethoxazole. These findings 
indicate that the local poultry industry is not compliant 
with Algerian biosafety legislation [10]. In Constantine 
(eastern Algeria), another study highlighted the huge 
prevalence of NTS in the broiler production chain in 
this region. It showed that 37% of broiler farms and 
53% of slaughterhouses were positive for Salmonella 
upon inspection. Five serovars (S. Hadar, S. Virchow, 
S. Infantis, S. Albany and S. Carnac) were recovered 
from both types of site, with S. Heidelberg and S. Rissen 
only found on farms and S. Typhimurium, S. Enteritidis 
and S. Montevideo only found in slaughterhouses 
(Table 1). Among the 55 isolates of NTS, 51% (39/55) 
were MDR and 80% (44/55) showed resistance to at 
least one antibiotic including streptomycin, 
tetracycline, nalidixic acid and ofloxacin (Table 2) [29]. 
A preliminary investigation was conducted for the 
prevalence of Salmonella contamination in laying-hen 
flocks in the neighboring regions of Annaba and El 
Taref (Figure 1). The most prevalent serovars isolated 
were S. Enteritidis, S. Kentucky, S. Hadar, S. Virchow, 
S. Heidelberg and S. Manhattan (Table 1) [28].  
During 2007, a surveillance study was conducted on 
different poultry farms in four Algerian cities: Tizi-
Ouzou, Bouira, Bejaïa, and Boumerdes which 
identified thirteen serotypes among 100 isolates (Figure 
1, Table 1) [35]. 
In Skikda, persistence of gastroenteritis infection 
within the poultry industry prompted an investigation 
for NTS in this sector in 2013. Of 27 poultry houses, 
34% were found to be contaminated with Salmonella; 
the main NTS serotypes isolated were S. Kentucky and 
S. Heidelberg, then S. Enteritidis, S. Virginia and S. 
Newport (Table 1) [33]. 
Table 1. Serotypes of Non-Typhoidal Salmonella isolated in different cities in Algeria. 
Salmonella 
serotypes 
City of isolation 
Source of isolation Study 
Year of 
Isolation 1 2 3 4 5 6 7 8 9 10 
S. Anatum +   +       Red meat, human [26, 27] 2006-08 
S. Altona +          Red meat [27] 2007-08 
S. Corvallis +          Red meat [27] 2007-08 
S. Enteritidis + + + + + + + +  + Red meat, poultry, human 
[23, 24, 26-28, 
30] 
2005-09 
S. Typhimurium +  + +  +   +  Red meat, poultry, human [11, 26, 27, 30] 2006-08 
S. Livingstone         +  Poultry [11] - 
S. Hadar    +   + +   Poultry [23, 24] 2005-09 
S. Virchow    +   + +   Poultry, human [23, 26] 2008-09 
S. Infantis    +      + Poultry, human [23, 26, 28] 2008-13 
S. Albany  + + + + +     Poultry [11, 30] 2005-07 
S. Carnac    +       Poultry [11, 30] 2005-07 
S. Heidelberg  + + + + + + +  + Poultry, human [24, 26, 28, 30] 2005-07 
S. Rissen    +       Poultry [24] 2005-07 
S. Montevideo    +       Poultry [24] 2005-07 
S. Blockley    +       Poultry [24] 2005-07 
S. Indiana    +       Human [26] 2006-07 
S. Kentucky    +       Human [26] 2006-07 
S. Senftenberg    +   + +  + Poultry, human [23, 26, 28] 2006-09 
S. Manhattan       + +   Poultry [23] 2008-09 
S. Virginia          + Poultry [28] 2011-13 
S. Newport          + Poultry [28] 2011-13 
1= Algiers. 2= Boumerdes. 3= Bouira. 4= Contantine. 5= Tizi-Ouzou. 6= Bejaia. 7= Annaba. 8=Eltaref. 9= Batna. 10= Skikda 
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These studies conducted on NTS infection in 
Algeria, provide evidence for the presence of highly 
drug resistant serotypes. The serotypes identified from 
broilers and human clinical cases in Algeria are largely 
similar to those usually present in broilers worldwide, 
particularly in Europe and the USA, as well as Africa 
[31,36,37]. This highlights that NTS infection and 
antimicrobial resistance are matters of concern in 
Algeria that need to be dealt with in a more 
comprehensive manner. 
As in many other developing countries, Algeria is 
facing a paucity of data on NTS infection, probably 
linked to poor diagnostic capacity and lack of 
epidemiological investigation. Effort should be focused 
upon the design and implementation of strategies for 
laboratory-based surveillance, which will in turn 
provide integrated data to public health authorities, 
allowing them to respond and intervene in NTS 
infection in an effective way. 
 
Antimicrobial resistant Salmonella across 
Africa 
Antimicrobials are used as common practice in 
modern food animal husbandry, for both therapeutic 
and prophylactic purposes [38]. Several studies suggest 
that antimicrobial resistance in NTS is promoted by the 
use of those antimicrobials in food animals [8,39-41]. 
The dissemination of Multi-Drug Resistant (MDR) 
Salmonella from animals to humans is a major adverse 
consequence for public health which is leading to a 
treatment failure in human infectious diseases [42]. 
Antibiotic resistance in NTS strains can be due to 
Table 2. Antimicrobial resistance patterns of NTS in Algeria and some North African countries. 
Country of 
isolation 
Serotypes Antibiotic resistance profile 
Source of 
isolation 
Study 
Year of 
Isolation 
Algeria S. Agona AMP. CEF. CTX. SXT. SU. GEN. STR Human [26] 2006-07 
 S. Albany NAL. OFX. STR Human [26] 2006-07 
 S. Enteritidis AMP. CAZ. SU. TET Human [26] 2006-07 
 S. Hadar AMP. NAL. OFX. STR. TET Human [26] 2006-07 
 S. Kentucky AMP. CAZ, CEF. CTX. GEN. KAN. SU. SXT Human [26] 2006-07 
 S. Senftenberg AMP. CAZ. CEF. CTX. GEM. KAN. NAL. STR. SU Human [26] 2006-07 
 S. Typhimurium AMP. CHL. SU. STR. TET Human [26] 2006-07 
 S. Kentucky AMP. CEF. STR. SXT. GEM. TET. NAL. OFX. ENR Poultry [23] 2006-07 
 S. Hadar AMP. CEF. STR. TET. NAL Poultry [23] 2006-07 
 S. Albany STR. NAL. OFX. ENR Poultry [24] 2006-07 
 S. Heilderberg STR. NAL. OFX Poultry [24] 2006-07 
 S. Heilderberg AMX. TIC. CTX. ATM. GEN. AK. SXT Human [28] 2001-13 
 S. Typhimurium AMX. AMP. TIC. PIP. STR. NAL. SU. CHL. TET Meat [27] 2007-08 
 S. Anatum STR. SU. TMP. SXT. F Meat [27] 2007-08 
 S.  Altona NA. Su Meat [27] 2007-08 
 S. Corvalis SU Meat [27] 2007-08 
 S. Enteritidis SU. F Meat [27] 2007-08 
Tunisia S. Enteritidis AMP. NAL. CAZ Human [41] 2006-07 
 S. Enteritidis AMP Human [41] 2006-07 
 S. Enteritidis N Human [41] 2006-07 
 S. Enteritidis AMP, TE Human [41] 2006-07 
 S. Enteritidis AMP, NA Human [41] 2006-07 
 S. Typhimurium AMP. NAL. GEM Human [41] 2006-07 
 S. Zanzibar AMP. TET. NAL. NEO. KAN Human [41] 2006-07 
 S. Muenster CHL. TET. NEO Human [41] 2006-07 
Egypt S. Typhimurium 
AMP. ERY. STR. TET. CO. SAM. SXT. CHL. NAL. GEM. 
AMC 
Human [13] 2014-15 
 S. Rubislaw AMP. ERY. STR. TET. SAM. SXT. CHL. NAL. GEM. AMC Poultry [13] 2014-15 
 S. Kiel AMP. ERY. TET. AMC Poultry [13] 2014-15 
 S. Derby ERY. STR. TET. AMC Duck [13] 2014-15 
Morocco S. Enteritidis AMP. SXT. NAL Human [39] 2000-08 
Senegal S. Kentucky STR. KAN. TOB. GEN AMK. SU. TMP. TET Human [40] 1999-09 
 S. Typhilurium STR. KAN. TOB. GEM. AMK. SU. TM Human [40] 1999-09 
AK: Amikacin, AMP: Ampicillin, AMX: Amoxicillin, ATM: Aztreonam,  CAZ: Ceftazidime, CEF: Cephalothin, CHL: Chloramphenicol, CO: Ceftriaxone, 
CTX: Cefotaxime, ENR: Enrofloxacin, ERY: Erythromycin, F: Furan, GEN: Gentamicin, KAN: Kanamycin, NAL: Nalidixic Acid, NEO: Neomycin, OFX: 
Ofloxacin, PIP: Piperacillin, SAM: Ampicillin-Sulbactam, STR: Streptomycin, SU: Sulfonamides, SXT: Trimethoprim-Sulfamethoxazole, TET: Tetracyclin, 
TIC: Ticarcillin, TOB: Tobramycin, TMP: Trimethoprim. 
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genetic mutations or through the acquisition of 
resistance encoding genes on mobile elements [9]. 
Plasmids are typical carriers of determinants that confer 
resistance against conventional antibiotics such as 
ampicillin, chloramphenicol and tetracycline [43]. 
However, the chromosome can also harbor these 
determinants, e.g. on the multidrug resistance region of 
Salmonella Genomic Island 1 (SGI1) [9].  
In Algeria, an increase in NTS has been observed 
among bacterial isolates in laboratories both clinically 
and in animals [30]. At present, the available data on 
NTS infection are not sufficient to understand the 
propagation of NTS through the food chain and into 
humans. One of the major consequences of such 
propagation could be resistance to antibiotics. More 
than 37% of broiler chain production were found to be 
infected with NTS in Constantine (Table 1) of which 
51% were MDR [29]. A separate study showed 58% of 
100 isolates demonstrated resistance to 
fluoroquinolones, particularly in S. Heidelberg [35]. It 
should be noted that an evaluation of risk factors 
showed that NTS infection in this region of Algeria is 
strongly linked to poor technical and hygiene practices 
[29]. 
The majority of antibiotic resistance determination 
in Algeria is based upon phenotypic characterization, 
and there is limited use of molecular biology to 
understand the spread of antibiotic resistance among 
food-borne bacteria. Multiple resistance types have 
been reported among different serotypes of NTS (Table 
2), indicating the potential risk facing human health in 
the country through consuming food contaminated with 
resistant strains of NTS. 
In Africa, the diversity of geography and low 
standards of living in many countries contribute to a 
lack of available data on NTS infection. Instead, 
estimations of the burden of drug resistant NTS 
infection must be made from isolated studies (Table 2). 
In Morocco, during the period 2000 to 2008, 
outbreaks were reported with high levels of antibiotic 
resistant S. Enteritidis isolated from humans [44]. 
During the same period in Senegal, NTS serotypes 
isolated from patients showed an increase in resistance 
to amoxicillin from 0.9% to 11.1%, and nalidixic acid 
from 0.9% to 26.7%. Most of the NTS serotypes were 
S. Enteritidis, S. Typhimurium and S. Kentucky  [45]. 
During 2006-2007 in Tunisia, several resistant NTS 
strains were isolated from human in different regions of 
the country, and most of them belonged to S. Enteritidis 
containing different patterns of resistance (Table 2)  
[46] . An Egyptian study conducted on Salmonella 
isolates from human and animals showed an increasing 
rate of antimicrobial resistance among NTS isolates 
between 2014 and 2015, in particular to erythromycin 
and tetracycline, and amoxicillin-clavulanic acid. This 
resistance was linked to over-use of antimicrobials in 
livestock [13]. In Kenya, among 342 NTS isolates, the 
prevalence of MDR strains reached 42% during 2003 
[47]. A more recent study in 2014 from Ghana reported 
high levels of MDR Salmonella phenotypes (n = 
59/115, 51.3%) harboring resistance to ampicillin, 
cefuroxime, amoxicillin/clavulanic acid, 
chloramphenicol, cotrimoxazole and tetracycline [48]. 
In 2012, the European Food Safety Authority and 
European Centre for Disease Prevention and Control 
reported high levels of resistance to tetracyclines in 
NTS strains isolated in the EU, with a rate of 85% in 
poultry and 91% in swine. Similar rates of resistance 
were reported to sulfonamides and ampicillin. 
However, resistance to cephalosporins was low with 
maximum of 10% in both poultry and swine [37]. 
Reports from the National Antimicrobial Resistance 
Monitoring System (NARMS) in 2011 showed that 
NTS strains were isolated in the United States with high 
levels of resistance, particularly to penicillin, 
sulfonamides and tetracyclines in poultry, cattle and 
swine [49]. 
 
Epidemiology of NTS 
As a result of consuming unsafe food, food-borne 
diseases have become a worldwide economic burden. 
Around 550 million individuals fall sick every year, 
including 220 million children under the age of 5 years 
[50]. Salmonella is one of the most reported causes of 
diarrheal disease globally [50]. In fact, the prevalence 
of Salmonella infection is higher than reported, because 
most infected people do not undergo copro-culture 
diagnosis [6].  
Epidemiology related to NTS varies depending 
upon serovar, and its ability to cause gastrointestinal or 
invasive infection. With certain subtypes, S. 
Typhimurium is recognized as capable of causing 
bacteremia, whereas S. Heidelberg, S. Dublin, and S. 
Choleraesuis represent a significant potential to cause 
hospitalization, and even death. In comparison, serovar 
S. Newport was observed to cause fewer fatalities than 
S. Typhimurium [8].  
Several outbreaks of food-borne infections of 
antibiotic resistant bacteria have been reported globally 
while individual epidemiology studies in more-
developed African countries provide some basic insight 
until more data are available [51]. Such information is 
essential to understand the prevalence of multidrug-
resistant Salmonella strains [45]. In Algeria, there are 
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very few epidemiological studies for NTS infection. 
During 2006 and 2007, a single epidemiological 
investigation was conducted on 100 strains of NTS 
from poultry and human clinical isolates in Constantine 
(Figure 1) in order to understand the contribution of 
avian NTS to human salmonellosis. Phenotypic and 
genotypic tests revealed a diversity among NTS 
serotypes (Table 2), but failed to confirm any 
association between the isolated serotypes even if they 
were collected in the same period of time [31].   
In other parts of Africa, particular serovars are 
prevalent in specific regions, namely S. Concord in 
Ethiopia [52], S. Bovismorbificans in Malawi [53], S. 
Stanleyville and S. Dublin in Mali [54], and S. Isangi in 
South Africa [55]. In Kenya, an average of 166 per 
100,000 children under five acquire an NTS infection 
every year [56,57]. In sub-Saharan Africa, a serious 
invasive form of NTS linked to S. Typhimurium 
sequence type 313 has emerged, and has become a 
leading public health issue in this region. This invasive 
S. Typhimurium had an estimated mortality rate of 20-
25% in children and up to 50% in adults [58].  
Food-borne Salmonella is the largest health burden 
of all bacterial pathogens in the US [59].  During 2014, 
a total of 19,057 laboratory-confirmed cases of food-
borne infections were identified. Salmonella was linked 
to 7439 of these cases, in which 2144 persons were 
hospitalized, and among them 32 patients died [60]. The 
most commonly detected serovars of Salmonella in 
humans include S. Enteritidis and S. Typhimurium, 
followed by S. Newport, S. Javiana, and Salmonella 
with the antigenic formula 4, [5], 12:i:- [61]. 
Although developed countries have a better 
awareness among food handlers and optimized 
surveillance programs, NTS infection has been detected 
and considered responsible for patient morbidity and 
mortality for decades. For developing countries, the 
situation worsened by the limited sources currently 
available. Due to robust globalization and scanty 
Salmonella surveillance programs in most developing 
countries, the world is now dealing with a new 
challenge from Salmonella enterica spp. that are 
potentially multidrug resistant [38] and may spread all 
over the food chain [38,62]. In addition, massive human 
migration from African countries and an increase in 
food trade between developing and developed countries 
may play a role in spreading such isolates all over the 
world. 
 
Conclusions 
NTS infection is a global issue with a higher 
prevalence and burden in developing countries such as 
Algeria. A strong foundation of reliable research data is 
needed to effectively describe NTS infection and trace 
public health consequences among the Algerian 
population. To achieve this aim, detailed national 
epidemiological and microbiological studies should be 
set up in order to evaluate the prevalence of NTS in 
every food of animal origin, determine which serovars 
are in circulation, and better understand the relationship 
between food production and outbreaks of human 
salmonellosis in Algeria.  
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